Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

AMICUS THERAPEUTICS, INC. Director's Dealing 2014

Apr 11, 2014

31523_dirs_2014-04-11_4de0f612-61d6-489c-95ea-e3e0cbc2af56.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AMICUS THERAPEUTICS INC (FOLD)
CIK: 0001178879
Period of Report: 2014-04-10

Reporting Person: Valenzano Ken (VP, Pharmacology & Biology)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2014-04-10 Common stock A 50000 $0.00 Acquired 51708 Direct

More from AMICUS THERAPEUTICS, INC.

Regulatory Filings 2026
Apr 27
Regulatory Filings 2026
Apr 27
Regulatory Filings 2026
Apr 27
Transaction in Own Shares 2026
Apr 27
Transaction in Own Shares 2026
Apr 27
Regulatory Filings 2026
Apr 27
Regulatory Filings 2026
Apr 27
Regulatory Filings 2026
Apr 27
Transaction in Own Shares 2026
Apr 27
Regulatory Filings 2026
Apr 27
View all filings →